These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1716558)

  • 41. Event-related potentials and visual spatial attention: influence of a cholinergic drug.
    Münte TF; Heinze HJ; Scholz MB; Bartusch SM; Dietrich DE
    Neuropsychobiology; 1989; 21(2):94-9. PubMed ID: 2615925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of diazepam on visual pattern-evoked potentials with due regard to nonstationary effects. Methodological problems.
    Böker T; Heinze HJ
    Neuropsychobiology; 1984; 11(3):207-12. PubMed ID: 6472606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resting state in Alzheimer's disease: a concurrent analysis of Flash-Visual Evoked Potentials and quantitative EEG.
    Tartaglione A; Spadavecchia L; Maculotti M; Bandini F
    BMC Neurol; 2012 Nov; 12():145. PubMed ID: 23190493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visual event-related potential in mild dementia of the Alzheimer's type.
    Saito H; Yamazaki H; Matsuoka H; Matsumoto K; Numachi Y; Yoshida S; Ueno T; Sato M
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):365-71. PubMed ID: 11442887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The interrelation of the level of the brain DC potential and visual evoked potentials during human aging: the norm and Alzheimer's disease].
    Fokin VF; Ponomareva NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(2):222-8. PubMed ID: 8023561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects.
    Bartel P; Blom M; Robinson E; Van der Meyden C; Sommers DO; Becker P
    Electroencephalogr Clin Neurophysiol; 1990; 77(5):330-9. PubMed ID: 1697524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual evoked potentials in mild senile dementia of Alzheimer type.
    Coben LA; Danziger WL; Hughes CP
    Electroencephalogr Clin Neurophysiol; 1983 Feb; 55(2):121-30. PubMed ID: 6185308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modality-specific changes in P300 parameters in patients with dementia of the Alzheimer type.
    Pokryszko-Dragan A; Słotwiński K; Podemski R
    Med Sci Monit; 2003 Apr; 9(4):CR130-4. PubMed ID: 12709671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic modelling of Alzheimer's disease.
    Sunderland T; Tariot PN; Weingartner H; Murphy DL; Newhouse PA; Mueller EA; Cohen RM
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):599-610. PubMed ID: 3541054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reliability of the Flash Visual Evoked Potential P2: Double-Stimulation Study.
    Wyatt-McElvain KE; Arruda JE; Rainey VR
    Appl Psychophysiol Biofeedback; 2018 Jun; 43(2):153-159. PubMed ID: 29808441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flash and pattern reversal visual evoked responses in normal and demented elderly.
    Brodie EE; Allan D; Brooks DN; McCulloch J; Foulds WS
    Cortex; 1992 Jun; 28(2):289-93. PubMed ID: 1499313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypersensitivity to scopolamine in the elderly.
    Flicker C; Ferris SH; Serby M
    Psychopharmacology (Berl); 1992; 107(2-3):437-41. PubMed ID: 1615141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of flash mode and intensity on P2 component latency and amplitude.
    Coburn KL; Amoss RT; Arruda JE; Kizer LD; Marshall YS
    Int J Psychophysiol; 2005 Mar; 55(3):323-31. PubMed ID: 15708645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of scopolamine on MEG spectral power and coherence in elderly subjects.
    Osipova D; Ahveninen J; Kaakkola S; Jääskeläinen IP; Huttunen J; Pekkonen E
    Clin Neurophysiol; 2003 Oct; 114(10):1902-7. PubMed ID: 14499752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scopolamine reduces frontal cortex perfusion.
    Honer WG; Prohovnik I; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1988 Oct; 8(5):635-41. PubMed ID: 3417793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender-based normative values for pattern-reversal and flash visually evoked potentials under binocular and monocular stimulation in healthy adults.
    Dotto PF; Berezovsky A; Sacai PY; Rocha DM; Salomão SR
    Doc Ophthalmol; 2017 Aug; 135(1):53-67. PubMed ID: 28560498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visual retinocortical function in dementia of the Alzheimer type.
    Kergoat H; Kergoat MJ; Justino L; Chertkow H; Robillard A; Bergman H
    Gerontology; 2002; 48(4):197-203. PubMed ID: 12053107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Visual evoked potentials in early Alzheimer's dementia: an exploratory study.
    Grayson AS; Weiler EM; Sandman DE
    J Gen Psychol; 1995 Jan; 122(1):113-29. PubMed ID: 7714499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visual evoked responses in Alzheimer's disease: a review.
    Moore NC
    Clin Electroencephalogr; 1997 Jul; 28(3):137-42. PubMed ID: 9241466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of L-DOPA/carbidopa on pattern reversal VEP: behavioural difference in primary and secondary parkinsonism.
    Sollazzo D
    Electroencephalogr Clin Neurophysiol; 1985 Oct; 61(4):236-42. PubMed ID: 2411501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.